Buyout includes $51.9 million payout to Synthes' top executive

12/5/2011 | MassDevice.com (Boston)

Michel Orsinger, CEO of Synthes, will receive a $51.9 million payout as part of a $21.3 billion acquisition by Johnson & Johnson. The buyout, which is expected to be completed early next year, will allow Johnson & Johnson to add Synthes to its DePuy unit, with Orsinger taking over as head of the company's new global orthopedics team.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN